AKASA vs Penguin Ai (2026)
Revenue cycle teams use AKASA and Penguin Ai to review documentation and move administrative work forward. AKASA packages hospital focused coding, documentation and status workflows with revenue cycle expertise; Penguin Ai offers a broader configurable platform spanning provider and payer operations. AKASA's Prebill Optimization Suite combines Coding Optimizer and CDI Optimizer to identify coding opportunities and documentation gaps. AI Advisor supports staff research, while Auth Status and Claim Status check payer portals and record results. Customers can use the tools with their own teams or AKASA's experts. Named hospital cases show status automation in use, while Cleveland Clinic's coding deployment does not yet carry reported outcomes. Penguin Ai's GwenOS combines data, policy context and software workers. Intelligent RCM reviews claims, prepares denial recovery and tracks payments against contracts. Glassbox exposes supporting record passages, rules and reviewer actions; specialists retain final approval and customers control submission. Native applications can run in customer Snowflake or AWS accounts. Its appeal and speed claims lack the study detail needed to project results. AKASA fits hospital teams buying defined revenue cycle solutions with an expert service option. Penguin Ai fits organizations configuring administrative applications across coding, authorization and claims, including those placing software in their own data environment. Both connect documentation review to coding, authorization and claim work performed by revenue cycle teams.
- Hospital coding and documentation integrity are the primary priorities.
- Payer status checks need automation with expert support.
- The organization wants defined solutions with production reporting.
- Internal staff may delegate workflows to revenue cycle specialists.
- Provider and payer administrative work should share a platform.
- Reviewers need source passages and policy rules beside findings.
- The organization wants applications in Snowflake or AWS accounts.
- Teams want configurable workers while retaining final submission control.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AKASA and Penguin Ai are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AKASA | Penguin Ai |
|---|---|---|
| Primary category | RCM & Prior Auth AI | Health System AI Platforms |
| Founded | Not recorded | 2024 |
| Headquarters | South San Francisco, California | Palo Alto, California, United States |
| Website | akasa.com | penguinai.co |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AKASA, formerly Alpha Health, sells generative AI for the provider side of the revenue cycle to hospitals and health systems. Its listed solutions are the Prebill Optimization Suite, which combines Coding Optimizer (missed coding opportunities, quality and compliance risks) and CDI Optimizer (documentation gaps for clinical documentation integrity teams); AI Advisor, a research assistant for revenue cycle staff; Auth Status, which checks pending prior authorization requests on payer portals and records the results; and Claim Status, which does the same for outstanding claims.
Source: AI Health Index, October 2026
Penguin Ai provides an administrative AI platform for health plans, providers, and healthcare service organizations. GwenOS combines a data foundation that resolves records across systems, a context layer for payer policies and clinical criteria, and software workers that prepare authorizations, coding recommendations, claims, and appeals.
Source: AI Health Index, October 2026
Questions buyers ask
How do AKASA and Penguin Ai work with the EHR?
AKASA's Montage Health case studies describe claim and authorization status automation working alongside Epic, returning detailed status information into the record to drive follow-up, and reducing an Epic authorization work queue by 22 percent.
With Penguin Ai, the data foundation accepts HL7, FHIR R4, X12, NCPDP, flat files, and custom feeds. Browser automation is available for portals without modern APIs, and workers return structured output for downstream systems. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
How are AKASA and Penguin Ai priced and sold?
AKASA sells to hospitals and health systems by solution, each with its own demo request. The platform page describes a dedicated account manager, production reporting, and the option of AKASA's own revenue cycle experts taking over workflows rather than staff using the tools, a service component that will shape the cost.
For Penguin Ai, the raw Sonnet language service lists $3 per million input tokens and $15 per million output tokens. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
How do AKASA and Penguin Ai handle patient data?
With AKASA, the data is complete clinical and financial documentation for whole health systems. Safety engineering, meaning guardrails, hallucination mitigation and how a safety event is handled, is not described.
In Penguin Ai's case, the Snowflake apps retain recommendations, overrides, and audit outcomes within the customer's account, while ordinary Gwen testing is restricted to synthetic data. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
What evidence is published for AKASA and Penguin Ai?
For AKASA, the 2024 Authorization Advisor launch claimed up to 50 percent less time on prior authorization and models 38 percent more accurate than GPT-4 at selecting documents, with no test set or method. Cleveland Clinic is deploying the coding and documentation tools, with no results published.
With Penguin Ai, the table omits case counts, reference labeling, evaluation dates, and uncertainty. September 2026 launch material adds a 93% appeal overturn claim and a reduction from 48 hours to as little as five minutes without the underlying study population. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
AKASA is based in South San Francisco and Penguin Ai in Palo Alto, California. Penguin's $450 monthly Gwen Pro plan covers synthetic data experimentation; production patient data requires Enterprise terms and security review. AKASA has no public pricing schedule.